Effect of ethylcellulose and propylene glycol on the controlled-release performance of glyceryl monooleate–mertronidazole periodontal gel

References

• Hanes PJ, Purvis JP. Local anti-infective therapy: pharmacological agents. A systematic review. Ann Periodontol 2003;8:79–98
   PubMedGoogle Scholar
• Vandekerckhove BNA, Quirynen M, VanSteenberghe D. The use of tetracycline containing controlled release fibers in the treatment of refractory periodontitis. J Periodontol 1997;68:353–361
   PubMed Web of Science ®Google Scholar
• Bollen CM, Quirynen M. Microbiological response to mechanical treatment in combination with adjunctive therapy. A review of the literature. J Periodontol 1996;67:1143–1158
   PubMed Web of Science ®Google Scholar
• Jain N, Jain GK, Javed S, et al. Recent approaches for the treatment of periodontitis. Drug Disc Today 2008;13:932–943
   PubMed Web of Science ®Google Scholar
• Krayer JW, Leite RS, Kirkwood KL. Non-surgical chemotherapeutic treatment strategies for the management of periodontal diseases. Dent Clin North Am 2010;54:13–33
   PubMedGoogle Scholar
• Herrera D, Alonso B, León R, et al. Antimicrobial therapy in periodontitis: the use of systemic antimicrobials against the subgingival biofilm. J Clin Periodontol 2008;35:S8:45–66
   Web of Science ®Google Scholar
• Stoltze K, Stellfeld M. Systemic absorption of metronidazole after application of a metronidazole 25% dental gel. J Clin Periodontol 1992;19:693–701
   PubMed Web of Science ®Google Scholar
• Rizzo A, Paolillo R, Guida L, et al. Effect of metronidazole and modulation of cytokine production on human periodontal ligament cells. Int Immunopharmacol 2010;10:744–750
   PubMed Web of Science ®Google Scholar
• Palmer RM, Matthews JP, Wilson RF. Adjunctive systemic and locally delivered metronidazole in the treatment of periontitis. Br Dent J 1998;184:548–552
   PubMed Web of Science ®Google Scholar
• Haffajee AD, Torresyap G, Socransky SS. Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1-year results. J Clin Periodontol 2007;34:243–253
   PubMed Web of Science ®Google Scholar
• Leiknes T, Leknes KN, Böe OE, et al. Topical use of a metronidazole gel in the treatment of sites with symptoms of recurring chronic inflammation. J Periodontol 2007;78:1538–1544
   PubMed Web of Science ®Google Scholar
• Shifrovitch Y, Binderman I, Bahar H, et al. Metronidazole-loaded bioabsorbable films as local antibacterial treatment of infected periodontal pockets. J Periodontol 2009;80:330–337
   PubMed Web of Science ®Google Scholar
• Engstroem S, Lindahl L, Wallin R, Engblom J. A study of polar lipid drug carrier systems undergoing a thermoreversible lamellar-to-cubic phase transition. Int J Pharm 1992;86:137–145
   Google Scholar
• Chang CM, Bodmeier R. Low viscosity monoglyceride based drug delivery systems transforming into a highly viscous cubic phase. Int J Pharm 1998;173: 51–60
   Web of Science ®Google Scholar
• Boyd BJ, Whittaker DV, Khoo S, Davey G. Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems. Int J Pharm 2006;309:218–226
   PubMed Web of Science ®Google Scholar
• Esposito E, Carotta V, Scabbia A, et al. Comparative analysis of tetracycline-containing dental gels: poloxamer- and monoglyceride-based formulations. Int J Pharm 1996;142:9–23
   Web of Science ®Google Scholar
• Ahmed AR, Dashevsky A, Bodmeier R. Drug release from and sterilization of in situ cubic phase forming monoglyceride drug delivery systems. Eur J Pharm Biopharm 2010;75:375–380
   PubMed Web of Science ®Google Scholar
• Chang CM, Bodmeier R. Swelling of and drug release from monoglyceride-based drug delivery systems. J Pharm Sci 1997;86:747–752
   PubMed Web of Science ®Google Scholar
• Shah JC, Sadhale Y, Chilukuri DM. Cubic phase gels as drug delivery systems. Adv Drug Deliv Rev 2001;47:229–250
   PubMed Web of Science ®Google Scholar
• Kumar MK, Shah MH, Mahadik KR, Paradkar A. Effect of drug solubility and different excipients on floating behaviour and release from glycerylmonooleate matrices. Int J Pharm 2004;272:151–160
   PubMed Web of Science ®Google Scholar
• Lara MG, Vitória M, Bentley LB, Collett JH. In vitro drug release mechanism and drug loading studies of cubic phase gels. Int J Pharm 2005;293:241–250
   PubMed Web of Science ®Google Scholar
• Shah MH, Paradkar A. Effect of HLB of additives on the properties and drug release from the glycerylmonooleate matrices. Eur J Pharm Biopharm 2007;67:166–174
   PubMed Web of Science ®Google Scholar
• Mathiowitz E. Encyclopedia of controlled drug delivery. 1st ed. NJ, USA: John Wiley and Sons, Inc.; 1999
   Google Scholar
• Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123–133
   PubMed Web of Science ®Google Scholar
• Ahmed AR, Dashevsky A, Bodmeier R. Drug release from and sterilization of in situ cubic phase forming monoglyceride drug delivery systems. Eur J Pharm Biopharm 2010;75:375–380
   PubMed Web of Science ®Google Scholar
• Wong CF, Yuen KH, Peh KK. An in-vitro method for buccal adhesion studies: importance of instrument variables. Int J Pharm 1999;180:47–57
   PubMed Web of Science ®Google Scholar
• Jones DS, Woolfson AD, Brown AF, O'Neill MJ. Mucoadhesive, syringeable drug delivery systems for controlled application of metronidazole to the periodontal pocket: in vitro release kinetics, syringeability, mechanical and mucoadhesive properties. J Contr Release 1997;49:71–79
   Web of Science ®Google Scholar
• Gonçalves GMS, Maia Campos PMBG. Shelf life and rheology of emulsions containingvitamin C and its derivatives. Rev Ciênc Farm Básica Appl 2009;30:217–224
   Google Scholar
• Vega E, Dabbene V, Nassetta M, Sola N. Validation of a reversed-phase LC method for quantitative analysis of intravenous admixtures of ciprofloxacin and metronidazole. J Pharm Biomed Anal 1999;21:1003–1009
   PubMed Web of Science ®Google Scholar
• Ritger PL, Peppas NA. A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the forms of slabs, spheres, cylinders or discs. J Contr Release 1987;5:23–26
   Google Scholar
• Papadopoulou V, Kosmidis K, Vlachou M, Macheras P. On the use of the Weibull function for the discernment of drug release mechanisms. Int J Pharm 2006;309:44–50
   PubMed Web of Science ®Google Scholar
• Berry MR, Likar MD. Statistical assessment of dissolution and drug release profile similarity using a model-dependent approach. J Pharm Biomed Anal 2007;45:194–200
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huo M, Zhou J, et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J 2010;12:263–271
   PubMed Web of Science ®Google Scholar
• Shah VP, Tsong Y, Sathe P, Liu J. In vitro dissolution profile comparison-statistics and analysis of the similarity factor, f2. Pharm Res 1998;15:889–896
   PubMed Web of Science ®Google Scholar
• Guidance for Industry: Modified release solid oral dosage forms: Scale–up and post–approval changes (SUPAC - MR): Chemistry, Manufacturing and Controls; In vitro dissolution testing, and in vivo bioequivalence documentation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research; 1997
   Google Scholar
• Yang M, Richmond CA, Chen H, Petaluma CA. US Patent: US20090197896 A1, 2009
   Google Scholar
• Farkas E, Zelko R, Németh ZS, et al. The effect of liquid crystalline structure on chlorhexidinediacetate release. Int J Pharm 2000;193:239–245
   PubMed Web of Science ®Google Scholar
• Costa-Balogh FO, Sparr E, Sousa JJ, Pais AC. Drug release from lipid liquid crystalline phases: relation with phase behavior. Drug Dev Ind Pharm 2010;36:470–478
   PubMed Web of Science ®Google Scholar
• Bansal K, Rawat MK, Jain A, et al. Development of satranidazole mucoadhesive gel for the treatment of periodontitis. AAPS PharmSciTech 2009;10:716–723
   PubMed Web of Science ®Google Scholar
• Nielsen LS, Schubert L, Hansen J. Bioadhesive drug delivery systems characterization of mucoadhesive properties of systems based on glycerylmonooleate and glycerylmonolinoleate. Eur J Pharm Sci 1998;6:231–239
   PubMed Web of Science ®Google Scholar
• Lee J, Young SA, Kellaway IW. Water quantitatively induces the mucoadhesion of liquid crystalline phases of glycerylmonooleate. J Pharm Pharmacol 2001;53:629–636
   PubMed Web of Science ®Google Scholar